September 4, 2022 at 12:19 pm

Otsuka’s New Drug Lists Akathisia as the Most Common “Side Effect”

A drug advertisement for the new product called Rexulti is marketed as an add-on drug to be taken with SSRIs and similar depression pills. Otsuka Pharmaceuticals lists akathisia as the most common “side effect” of Rexulti but fails to mention that polypharmacy and simultaneously taking two drugs that can cause akathisia increases your risk of suffering from this serious drug-induced disorder. Also, see the drug ad promotes some new guesses as to what “may” cause depression. See